as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High

-0.16%
Downside
3.77%
Upside

52 Week's Low
52 Week's High

57.44%
Downside
6.46%
Upside

Check Ideaya Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.9B
EPS (TTM)
-3.1018
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-21.52
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-381.8M
Revenue (TTM)
7.0M
Profit Margin
0.00%
Return On Equity TTM
-35.09%
Track how Ideaya Biosciences Inc P/E has moved over time to understand its valuation trends.
Ideaya Biosciences Inc in the last 5 years
Lowest (-21.40x)
June 30, 2021
Today (-21.52x)
October 30, 2025
Industry (8.36x)
October 30, 2025
Highest (-5.06x)
June 30, 2025
Today’s Price to Earnings Ratio: -21.52x
Compare market cap, revenue, PE, and other key metrics of Ideaya Biosciences Inc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $2.9B | 164.42% | -21.52 | 0.00% | |
| BUY | $62.4B | 291.63% | -505.15 | -12.96% | |
| NA | $36.4B | NA | NA | -3.89% | |
| BUY | $108.3B | 100.24% | 30.02 | 31.86% | |
| BUY | $69.4B | 20.12% | 15.7 | 32.13% | 
The Ideaya Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ideaya Biosciences Inc investment value today
Current value as on today
₹1,12,931
Returns
₹12,931
(+12.93%)
Returns from Ideaya Biosciences Inc Stock
₹7,264 (+7.26%)
Dollar Returns*
₹5,667 (+5.67%)
Based on 17 analysts
94.12%
Buy
5.88%
Hold
0.00%
Sell
Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Ideaya Biosciences Inc. Average target price of $48.12
Get share price movements and forecasts by analysts on Ideaya Biosciences Inc.
What analysts predicted
34.33%UPSIDE
Target Price
$48.12
Current Price
$31.6
Analyzed by
17 Analysts
Target
$48.12
Ideaya Biosciences Inc target price $48.12, a slight upside of 34.33% compared to current price of $31.6. According to 17 analysts rating.
Search interest for Ideaya Biosciences Inc Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:3% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 3.92M → 7.0M (in $), with an average increase of 44.0% per quarter
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 7 days, IDYA stock has moved up by 10.3%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.6% return, outperforming this stock by 66.3%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.4% return, outperforming this stock by 41.9%
 NEGATIVE IMPACT
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, -71.40M → -77.49M (in $), with an average decrease of 8.5% per quarter
| Organisation | Ideaya Biosciences Inc | 
| Headquarters | 5000 Shoreline Court, South San Francisco, CA, United States, 94080 | 
| Industry | Biotechnology | 
| CEO | Mr. Yujiro S. Hata | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Mr. Andres Ruiz Briseno CPA | Chief Accounting Officer | 
| Dr. Darrin M. Beaupre M.D., Ph.D. | Chief Medical Officer | 
| Mr. Stuart C. Dorman | Chief Commercial Officer | 
| Mr. Douglas B. Snyder | Senior VP & General Counsel | 
| Ms. Francine Zelaya | Vice President & Head of Human Resources | 
| Mr. Yujiro S. Hata | Founder, President, CEO & Director | 
| Dr. Michael A. White Ph.D. | Chief Scientific Officer | 
| Dr. Joshua Bleharski Ph.D. | Chief Financial Officer | 
| Dr. Paul A. Barsanti Ph.D. | Chief Technology Officer | 
| Mr. Mick O'Quigley | Chief of Staff & Clinical Development | 
Ideaya Biosciences Inc share price today is $31.6 as on at the close of the market. Ideaya Biosciences Inc share today touched a day high of $32.79 and a low of $31.65.
Ideaya Biosciences Inc share touched a 52 week high of $33.64 on and a 52 week low of $13.45 on . Ideaya Biosciences Inc stock price today i.e. is closed at $31.6,which is 6.06% down from its 52 week high and 134.94% up from its 52 week low.
Ideaya Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ideaya Biosciences Inc (IDYA) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.86 in Ideaya Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Ideaya Biosciences Inc share’s latest price of $31.6 as on October 31, 2025 at 1:29 am IST, you will get 0.3165 shares of Ideaya Biosciences Inc. Learn more about
          
            fractional shares .
        
Ideaya Biosciences Inc stock has given 164.42% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?